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Abstract
Objective. To assess whether there is a relationship between having quality as an item on the board’s agenda, perceived external
pressure (PEP) and the implementation of quality management in European hospitals.
Design. A quantitative, mixed method, cross-sectional study in seven European countries in 2011 surveying CEOs and quality
managers and data from onsite audits.
Participants.One hundred and fifty-five CEOs and 155 quality managers.
Setting. One hundred and fifty-five randomly selected acute care hospitals in seven European countries (Czech Republic,
France, Germany, Poland, Portugal, Spain and Turkey).
Main outcome measure(s). Three constructs reflecting quality management based on questionnaire and audit data: (i) Quality
Management System Index, (ii) Quality Management Compliance Index and (iii) Clinical Quality Implementation Index. The
main predictor was whether quality performance was on the executive board’s agenda.
Results. Discussing quality performance at executive board meetings more often was associated with a higher quality manage-
ment system score (regression coefficient b= 2.53; SE = 1.16; P= 0.030). We found a trend in the associations of discussing
quality performance with quality compliance and clinical quality implementation. PEP did not modify these relationships.
Conclusions. Having quality as an item on the executive board’s agenda allows them to review and discuss quality performance
more often in order to improve their hospital’s quality management. Generally, and as this study found, having quality on the
executive board’s agenda matters.
Keywords: quality management, executive board, quality on the agenda, external pressure, international research, acute care hospitals
†Full details of the authors of The DUQuE Project Consortium are given in the Appendix.
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Introduction
Executive boards in hospitals are under increasing pressure to
assure and improve the quality of care delivered to patients. They
have to improve management systems to meet the demands of a
wide range of stakeholders [1]. External pressures such as ac-
creditation [2, 3], publicly available performance data [4, 5] and
market competition [6] have been associated with organizational
changes. Since executive boards have the responsibility of daily
management of the hospital, external pressures can play a
pivotal role in the prioritization and agenda-setting of the execu-
tive board. Agenda setting is considered to be the starting point
of prioritization and decision-making [7], and having quality on
the agenda should allow executive board members to review
and discuss the quality and performance of the services they
deliver to patients.
However, it is not self-evident that executive boards drive the
quality and safety agenda within their organizations. Executive
boards tend to primarily focus on the hospital’s financial health,
at the expense of considering quality and safety issues [8–10].
The lack of active engagement of executive boards in quality
of care aligns with the growing concern that (financial) incen-
tives within healthcare systems are often failing to support
quality improvement (QI), i.e. the business case for quality is
lacking [11].
In previous studies, the executive board’s engagement was
found to be associated with the successful implementation of
QI projects [12–14], for example, by facilitating a supportive
IT systems [15] and stimulating clinical involvement in total
quality management [16]. Executive board’s engagement was
also found to be associated with adequately funded and sys-
tematically evaluated quality management systems [17, 18]. A
quality management system has been defined as a set of inter-
acting activities, methods and procedures used to monitor,
control and improve the quality of care [19], and is considered
to be a prerequisite for the successful implementation of single
QI projects [20] and to achieve sustainability.
There are different ways to assess quality management systems
[21], but whichever assessment was used, the implementation of
quality management systems appeared to differ between hospitals
[20, 22–25]. Thus far, it remains unclear why the implementation
of quality management systems differs.
Against this background, the aims of our study were to (i) de-
termine how often executive boards have quality performance as
an item on the agenda, (ii) investigate the relationship between
having quality on the board agenda and the implementation of
quality management in hospitals, and finally to (iii) explore the
influence of external pressure on this relationship.
Methods
Participants
This study was part of the ‘Deepening our Understanding of
Quality improvement in Europe (DUQuE)’ project, funded
by the EU 7th Research Framework Program [26]. Its aims
and methods are described elsewhere [27]. The study used a
multi-method, cross-sectional design to collect quality-related
information from European hospitals between May 2011
and February 2012 [27]. Seven countries were included based
on a mix of health and hospital system financing and organi-
zation criteria in different geographical areas in Europe.
The participating countries comprised the Czech Republic,
France, Germany, Poland, Portugal, Spain and Turkey. In each
country, 30 hospitals were randomly recruited, subject to them
having more than 130 beds and that they treat acute myocar-
dial infarct, hip fracture, stroke and deliveries patients [27].
Measuring the constructs
We sent a questionnaire to the Chief Executive Officers (CEOs)
to assess how frequently quality performance was an item on
the Executive board’s agenda: (i) never, or during, (ii) a few, (iii)
most, or (iv) every meeting.
The implementation of hospital-wide quality management
was measured using three constructs that focused on (i)
organization-wide systems, (ii) compliance and (iii) clinical
quality efforts. The implementation of the quality management
system was determined by the construct Quality Management
System Index (QMSI) [28]. This was based on the quality
manager questionnaire and consists of (i) quality policy docu-
ments, (ii) quality monitoring by the board, (iii) training of pro-
fessionals, (iv) formal protocols for infection control, (v)
formal protocols for medication and patient handling, (vi) ana-
lysing performance of care processes, (vii) analysing perform-
ance of professionals, (viii) analysing feedback patient
experiences and (ix) evaluating results. The QMSI ranges from
0 to 27. The level of compliance was measured using the con-
struct Quality Management Compliance Index (QMCI) [29]. It is
based on audit data and assesses (i) quality planning, (ii) moni-
toring patient/professional opinion, (iii) monitoring quality
systems and (iv) improving quality by staff development. The
QMCI ranges from 0 to 16. Third, the Clinical Quality
Implementation Index (CQII) [29], which is also based on audit
data, assesses (i) preventing hospital infection, (ii) medication
management, (iii) preventing patient falls, (iv) preventing
patient ulcers, (v) routine testing of elective surgery patients,
(vi) safe surgery practices and (vii) preventing deterioration.
The CQII ranges from 0 to 14.
Perceived external pressure
Perceived external pressure (PEP) reflects the CEO’s percep-
tion of the influence external factors from outside the hospital
have on the hospital’s quality management system. Since there
was no validated scale to measure PEP, we asked experts from
the participating countries to provide an overview of pressures
applicable to hospitals in their country. We identified 18 differ-
ent external influencing factors (Table 2). Because the
meaning of these factors might differ across national cultures
and regulatory environments, the items were discussed with
the national coordinators from each country as part of the
translation process. In the questionnaires, CEOs could indicate
how much they considered each single item to have influence
on their quality management system (0, no influence;
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1, moderate influence; 2, major influence). The composite
measure of PEP was constructed by the sum score of 18 exter-
nal influencing factors. Items were not weighted since it was
beyond the scope of this study to determine which factors are
more important than others. The composite measure for PEP
ranges from 0 to 36.
Data collection process
Country coordinators approached and recruited hospitals for this
study. Hospital coordinators forwarded passwords to the CEO
and quality manager to access the web-based questionnaires.
In total, 188 hospitals agreed to participate. Questionnaires were
completed by 177 (RR= 94%) CEOs and 188 quality managers
(RR= 100%). We collected audit data during onsite visits within
a subsample of 12 hospitals that were randomly selected from the
30 participating hospitals per country.
Statistical analyses
Data cleaning was performed prior to the statistical analyses.
In our data, 53 out of 188 (28.19%) hospitals were missing at
least one value for QMSI and 84 out of 188 (44.68%) of hos-
pitals were missing at least one of the external influencing
factors that were used to build the PEP score. In order to miti-
gate this, we used multiple imputation to obtain data sets that
were complete on subscale variables used to build QMSI and
PEP. The estimated values were based on the items that were
completed by the respondent and on the same item answered
by other respondents. Instead of a single fixed value, multiple
imputation replaces missing values with a set of plausible
values to represent practical uncertainty [30]. It generated five
complete data sets and these were used to construct scores of
QMSI, QMCI, CQII and PEP for hospitals that missed less
than half of the variables used to build each scale. Hospitals
missing more than half of the variables were excluded from the
analyses. This allowed us to increase our final sample size to 155
hospitals. Since only two CEOs indicated that they never dis-
cussed quality performance, we combined this answering cat-
egory with ‘during few meetings’ in further analyses. Audit data
(i.e. QMCI and CQII) were collected in 63 of the 155 hospitals.
Descriptive statistics were calculated to describe hospital
characteristics (teaching status, ownership and size) and demo-
graphic characteristics of participating CEOs and quality managers
(gender, age and number of years in job). Descriptive statistics are
also reported for the QMSI, QMCI and CQII (outcomes) and
how often was quality on the Board’s agenda (predictor) in the
analysis.
We used the Directed Acyclic Graph (DAG) shown in Fig. 1
to guide our analysis. We analysed the relationship between the
frequency of having quality on the executive board’s agenda
(predictor) with the implementation of quality management as
measured by QMSI, QMCI and CQII (outcomes). We used
linear random intercept models to estimate associations
between each of our three outcomes (QMSI, QMCI, CQII) and
the frequency of quality on the agenda and to assess whether
PEP modified this predictor–outcome relationship. Models
included a random intercept for country in order to account for
clustering of hospitals within countries. We also adjusted for
hospital confounders such as CEO background in healthcare,
hospital teaching status, ownership type and number of beds
because we expect that these variables might influence the fre-
quency of having quality on the agenda. To determine statistical
differences, the level of significance was set at 5%. All statistical
analyses were carried out in SAS (version 9.3, SAS Institute Inc.,
NC, USA, 2001).
Results
Quality on the executive board’s agenda
As can be seen in Table 1, the 155 hospitals are non-teaching
(55.5%) and teaching (44.5%), and 80% of the hospitals are
publicly owned. The executive boards comprised eight
members on average. Further analyses showed that the average
number of executive board members in France and Spain is
more than 10, while in Germany, Poland and Portugal, boards
have four or five members (not in the table). CEOs indicated
that the executive boards have 36 official meetings per year on
average, and 54% had quality performance on the agenda
during most meetings. Seventy-nine per cent of the executive
boards had at least one member with medical background.
Quality management
The implementation of quality management was described by
QMSI, QMCI and CQII. As shown in Table 1, the average
score on QMSI was 19.16 (±4.48) on a scale of 0–27. This
means that the majority of hospitals fully implemented quality
activities in at least one unit. The QMCI score was 10.52
(±3.18) on a scale of 0–16, meaning that the majority of
hospitals demonstrated compliance to a set of activities to
plan, control and monitor quality of care. Hospitals scored
Figure 1 The DAG shows the relationship between the
frequency of having quality on the executive board’s agenda
and the implementation of quality management. Hospital
confounders are teaching status, ownership, the number of
beds and the country the hospital is situated in. PEP is the
CEO’s perception of external pressure on the hospital’s quality
management system. PEP is hypothesized to by a modifier of
the relationship between the quality agenda and quality
management.
Botje et al.
94
8.39 ± 2.99 on CQII (on a scale of 0 to 14), meaning that proto-
cols existed in most of the seven areas of clinical quality efforts,
but that they were less frequently monitored and measured.
Perceptions of external pressure
On the whole, CEOs indicated that their hospital’s quality
management system is only moderately influenced by external
pressures (PEP score = 19.49 ± 5.88 on a scale of 0–36), with
an inter-quartile range of 8.6 between the first and the third
quartile. ‘Governmental policy’ and ‘legislation for internal
quality systems’ were perceived to have the most influence
(Table 2), which were similar for all seven countries. Albeit
that the external factors that appeared to have the least influ-
ence were missing more frequently, the missing values were
not considered systematic.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Descriptive statistics for the outcome, predictors, and characteristics of hospitals, CEOs and quality managers used in
the analysis (n= 155)a
Hospital characteristics
Teaching status, n (%)
Non-teaching 86 (55.48)
Teaching 69 (44.52)
Ownership, n (%)
Private 31 (20.00)
Public 124 (80.00)
Number of beds, n (%)
≤200 15 (9.68)
201–500 66 (42.58)
501–1000 48 (30.97)
>1000 26 (16.77)
Board size, mean (SD)b 7.93 (6.28)
Members with medical background, n (%)
0 members 22 (14.19)
1 member 55 (35.48)
2 members 42 (27.10)
3 or more members 26 (16.77)
Missing 10 (6.45)
Number of official Board meetings per year, mean (SD)c 36.34 (24.80)
Frequency of quality performance on the agenda of Board meetings, n (%)
Never on the agenda for meetings 2 (1.29)
Few meetings 43 (27.74)
Most meetings 84 (54.19)
Every meeting 26 (16.77)
Perceived external pressure (range 0–36), mean (SD) 19.49 (5.88)
Quality Management System Index (range 0–27), mean (SD) 19.16 (4.48)
Quality Management Compliance Indexa (range 0–16), mean (SD) 10.52 (3.18)
Clinical Quality Implementation Indexa (range 0–14), mean (SD) 8.39 (2.99)
Respondent characteristics
Sex, n (%) CEO QM
Male 132 (85.16) 48 (30.97)
Female 23 (14.84) 107 (69.03)
Age (years), mean (SD) 52.64 (6.80) 45.01 (8.81)
Number of years as in job, mean (SD) 5.03 (4.33) 4.61 (3.16)
Background in healthcare
No 14 (9.03) –
Yes 141 (90.97) –
aAudit data were collected in 63 of 155 hospitals in this study. Hospital characteristics of these 63 hospitals were similar to those of the 155
hospitals.
bInformation on number of executive board members missing in 11 hospitals.
cInformation on number of executive board meetings in the last year missing in 10 hospitals.
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Quality as an item on the executive board’s agenda
and the implementation of quality management
Table 3 details the regression coefficients, standard errors and
P-values from the multivariable adjusted regression models of
frequency of having quality performance on the executive
board’s agenda as predictor of QMSI, QMCI and CQII. After
adjusting for CEO background in healthcare and hospital
characteristics (teaching status, ownership type and size), hos-
pitals where the executive boards had quality on the agenda
during every meeting scored 2.532 units higher on QMSI
compared with hospitals with executive boards that discussed
it during few meetings or never (SE = 1.16; P= 0.03). We also
looked at modification effect of PEP on the relationship
between the frequency of having quality on the agenda and
QMSI by redoing the analysis without PEP, but did not find a
significant effect.
Table 3 also details the regression coefficients for the fre-
quency of having quality performance on the executive board’s
agenda as predictor of QMCI. Although our results were non-
significant, we observed positive associations between frequency
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Descriptive statistics for items used to calculate the PEP score (n = 155)
External influencing factorsa Mean SD Floor (% with
lowest score)
Ceiling (% with
highest score)
Frequency of
missing data
Governmental policy on quality and safety in healthcare 1.59 0.57 4 63 1
Legislation for internal quality systems 1.56 0.58 5 59 4
Public health, sanitary inspection 1.46 0.64 8 53 3
Hospital accreditation 1.45 0.77 16 59 7
Quality system certification (ISO 9004) 1.37 0.76 16 51 8
Statutory inspection to maintain institutional license,
registration
1.33 0.73 15 46 5
Accreditation of clinical training 1.29 0.68 12 40 7
Publication disclosure of hospital performance data
(e.g. public hospital comparisons, star ratings or league
tables)
1.23 0.61 9 32 6
Public relations, media pressure 1.12 0.63 14 25 8
Market competition advantage 1.03 0.68 20 23 10
Requirements for public liability, malpractice insurance 0.90 0.72 24 23 13
Clinical professional associations, colleges, societies 0.87 0.63 25 13 11
Professional chambers/regulators 0.85 0.69 30 16 13
Health insurance funds 0.78 0.76 37 18 16
Technology assessment bodies, e.g. HAS, NICE, SIGN 0.71 0.78 43 17 21
Condition for access to funding, e.g. as ‘preferred
provider’
0.66 0.76 45 15 19
Hospital associations 0.57 0.65 47 8 14
Ombudsman 0.57 0.64 46 7 17
aAll external influencing factors were rated on a scale range of 0–2; 0, no influence; 1, moderate influence; and 2, major influence.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Regression coefficients (standard errors) for the associations of having quality performance on the executive board’s
agenda and hospital level quality measures QMSI, QMCI and CQII, and the modifier PEP
QMSIa (n = 155) QMCIa (n= 63) CQIIa (n= 63)
b (SE) P-value b (SE) P-value b (SE) P-value
Frequency of quality on executive board’s agenda
Every meeting 2.53 (1.16) 0.030 1.23 (1.32) 0.355 1.85 (1.16) 0.117
Most meetings 1.62 (0.78) 0.040 0.86 (0.90) 0.340 1.81 (0.77) 0.023
Never/few meetings Ref. Ref. Ref. Ref. Ref. Ref.
Perceived external pressures score (PEP) 0.06 (0.06) 0.364 0.03 (0.08) 0.701 0.07 (0.07) 0.369
aAdjusted for country, CEO background in healthcare, hospital teaching status, ownership type, number of beds. Interaction effects of the
quality agenda and PEP were not significant for any outcome measure and therefore not shown.
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of quality on the agenda and QMCI. No effect or modification
effect was found for PEP on the association between fre-
quency of quality on the agenda and QMCI.
All else held constant, on average CQII score was higher
when executive boards had quality performance on the agenda
during most meetings (b = 1.81, SE = 0.77, P= 0.02) or
during every meeting (b = 1.85, SE = 1.16, P = 0.11), when
compared with hospitals where quality was discussed never or
at a few meetings. We did not find a modification effect of
PEP on this relationship.
Discussion
The aim of this study was to assess how frequently executive
boards in European hospitals have quality as an item on their
agenda, and whether this frequency is associated with the im-
plementation of hospital quality management. We have
demonstrated that executive boards which take an interest in
quality performance, as indicated by having the item on the
agenda, are more likely to have a quality management system
in place.
Agenda-setting is an important aspect of prioritization [7],
and ultimately for hospital governance. In order to take action,
executive boards should receive information about quality per-
formance, review and discuss it during meetings, and make the
right decision accordingly [31]. Having quality as an item on
the executive board’s agenda is also important symbolically as
it signals their quality orientation to the rest of the hospital,
and ultimately obtain more resources than those who do not
[32]. Therefore, having quality as an item on the agenda fits
well within QI cycles. Frequent discussions of quality perform-
ance demonstrate that executive boards consider quality of
care to be an important topic and provides the opportunity to
ascertain the implementation of the quality management
system. The association with quality management could also
mean that having a widely implemented quality management
system requires executive boards to have many meetings to
cover all its different subdimensions. Either way, discussing
quality performance seems to be an essential lever for imple-
menting and sustaining hospital-wide quality management.
The non-significant trend with compliance (QMCI) and clinic-
al implementation (CQII) of quality management could be
attributed to the lower number of hospitals participating in the
audit study. However, in order to get a better understanding of
the role of executive boards and clinicians in quality manage-
ment, further and more sustained research is needed to investi-
gate the relationship with quality strategies at pathway level.
Also this article reports on the CEO’s ranking of PEP.
Although we did not find a modification effect of PEP, we did
find that CEOs experienced pressure from external factors.
Where external pressure from patient demands, financial pres-
sure and market competition increase, executive boards are
under increasing scrutiny to shift their focus in decision-
making [33–35]. For example, publicly reported performance
data can lead to increased managerial commitment to quality
of care, reshape organizational priorities, and create a sense of
accountability [5]. In previous studies, quality management
systems were found to be more apparent in hospitals that were
subject to accreditation and certification [36, 37].
Limitations
Common limitations of the DUQuE project are described
elsewhere [27]. Our study has a number of specific limitations.
First, the information we obtained via questionnaires was
based on self-reported data, which might induce socially desir-
able bias and false-positive results. We tried to minimize this
by designing factual questions rather than asking for personal
opinions as much as possible. By using different data sources,
we tried to avoid the common problem of method variance.
Second, our aggregation methods could have influenced the
outcome of the regression analyses. However, we used vali-
dated scales as much as possible. Third, international research
on external pressure needs to take account and control for im-
portant confounding contextual and local contingent differ-
ences across countries that may influence the findings.
Therefore, we corrected for country differences in the ana-
lyses. So far, we have not been able to find an instrument that
aims to include in a single tool the capacity to rank the per-
ceived importance of different types of external pressure. It is
not the goal of this paper to validate this instrument, but this
publication appears to be the first attempt to measure this
concept. Last, we collected quantitative rather than qualitative
data. Albeit that qualitative research could give more insight in
what is discussed when quality performance is on the executive
board’s agenda, and how the required information is acquired
and used, for now it is a promising start to have determined
the aforementioned relationships quantitatively.
Practical implications
Executive boards are legally responsible for the hospital’s
quality performance, and this article demonstrates that they can
make a difference. Frequent discussions of quality performance
in the executive board room will keep them informed and
stimulate the implementation of quality management. Our pan-
European study design, including public teaching and non-
teaching hospitals, provides important cross-national lessons for
hospitals as they seek to improve the quality of care they deliver
to patients.
Conclusions
Having quality on the executive board’s agenda allows them to
review and discuss quality performance more often in order to
improve their hospital’s quality management. Generally, and
our study supports this, having quality on the executive board’s
agenda therefore matters.
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